Your browser doesn't support javascript.
loading
A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer.
Ding, Nan; You, A-Bin; Yang, Hu; Hu, Guo-Sheng; Lai, Chun-Ping; Liu, Wen; Ye, Feng.
Afiliação
  • Ding N; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, P.R. China.
  • You AB; The Third Clinical Medical College, Fujian Medical University, Fuzhou, P.R. China.
  • Yang H; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, P.R. China.
  • Hu GS; The Third Clinical Medical College, Fujian Medical University, Fuzhou, P.R. China.
  • Lai CP; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, P.R. China.
  • Liu W; State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. China.
  • Ye F; Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. China.
Clin Cancer Res ; 29(11): 2095-2109, 2023 06 01.
Article em En | MEDLINE | ID: mdl-36951687

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / MicroRNAs Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / MicroRNAs Idioma: En Ano de publicação: 2023 Tipo de documento: Article